THE IMMUNOGENIC PART OF INFLIXIMAB LIES WITHIN THE FAB2 FRAGMENT, BUT MEASUREMENT OF ANTIBODIES AGAINST INTACT INFLIXIMAB IS MORE CLINICALLY USEFUL

(1) Gastroenterology, Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel



This item was part of the Anti TNF therapy in IBD: Current to future session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A70